EuroPCR 2008

Customisable Drug Eluting Stents: A Breakthrough Approach to the Percutaneous Treatment of CAD

Wednesday May 14th

5:00-6:30pm, Room 5

Chairperson: W. Wijns

XTENT Custom NX Technical Overview

B. De Bruyne

Biolimus A9 and Biodegradable PLA Pre-Clinical Results

R. Virmani

CUSTOM Clinical Program

E. Grube

Long and Multilesion Case Review

R. Mueller, P. Stella

XTENT Exhibit Location: E11